Treatment for relapsed/refractory sickness need to be made the decision according to prior therapy as well as The key reason why why the initial remedy was now not proper (e.g., refractoriness vs. intolerance). Ibrutinib is The existing gold common therapy for patients with relapsed/refractory ailme